CompletedNot applicableNCT02861963

Choice of Palliative Procedures for Pulmonary Atresia With Ventricular Septal Defect Patients

Studying Pulmonary atresia with ventricular septal defect

Last synced from ClinicalTrials.gov May 19, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Meshalkin Research Institute of Pathology of Circulation
Principal Investigator: Alexander Y Omelchenko, PhD
Meshalkin Research Institute of Pathology of Circulation
Intervention: Experimental: RVOT reconstruction by femoral allogenic vein valve conduit(procedure)
Enrollment: 24 enrolled
Eligibility: 1 years · All sexes
Timeline: 2016 – 2019

Study locations (1)

Novosibirsk State Research Institute of Circulation Pathology, Novosibirsk, Russia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02861963 on ClinicalTrials.gov

← Back to all trials